Chandrika Prasad

Array ( [id] => 1517934 [patent_doc_number] => 06500929 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Membrane-bound C1 inhibitor' [patent_app_type] => B1 [patent_app_number] => 09/519878 [patent_app_country] => US [patent_app_date] => 2000-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 12 [patent_no_of_words] => 9007 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500929.pdf [firstpage_image] =>[orig_patent_app_number] => 09519878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1319004 [patent_doc_number] => 06605588 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-12 [patent_title] => 'Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis' [patent_app_type] => B1 [patent_app_number] => 09/517849 [patent_app_country] => US [patent_app_date] => 2000-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 38 [patent_no_of_words] => 34940 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605588.pdf [firstpage_image] =>[orig_patent_app_number] => 09517849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1543002 [patent_doc_number] => 06372715 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Use of erythropoientin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases' [patent_app_type] => B1 [patent_app_number] => 09/485371 [patent_app_country] => US [patent_app_date] => 2000-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6068 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372715.pdf [firstpage_image] =>[orig_patent_app_number] => 09485371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4284535 [patent_doc_number] => 06210925 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Direct expression of peptides into culture media' [patent_app_type] => 1 [patent_app_number] => 9/500009 [patent_app_country] => US [patent_app_date] => 2000-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 29 [patent_no_of_words] => 6803 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/210/06210925.pdf [firstpage_image] =>[orig_patent_app_number] => 500009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1175756 [patent_doc_number] => 06747003 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-08 [patent_title] => 'Modified vitamin K-dependent polypeptides' [patent_app_type] => B1 [patent_app_number] => 09/497591 [patent_app_country] => US [patent_app_date] => 2000-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 26 [patent_no_of_words] => 21149 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/747/06747003.pdf [firstpage_image] =>[orig_patent_app_number] => 09497591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1304470 [patent_doc_number] => 06620917 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-16 [patent_title] => 'Method for the purification and aqueous fiber spinning of spider silks and other structural proteins' [patent_app_type] => B1 [patent_app_number] => 09/490291 [patent_app_country] => US [patent_app_date] => 2000-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 11512 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/620/06620917.pdf [firstpage_image] =>[orig_patent_app_number] => 09490291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 627069 [patent_doc_number] => 07135452 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-11-14 [patent_title] => 'Recombinant SP-A for the treatment or prevention of pulmonary infection and inflammation' [patent_app_type] => utility [patent_app_number] => 09/889348 [patent_app_country] => US [patent_app_date] => 2000-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4649 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/135/07135452.pdf [firstpage_image] =>[orig_patent_app_number] => 09889348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1346610 [patent_doc_number] => 06579715 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-17 [patent_title] => 'Mammalian cortexin-like proteins and polynucleotides encoding the same' [patent_app_type] => B1 [patent_app_number] => 09/484906 [patent_app_country] => US [patent_app_date] => 2000-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12656 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579715.pdf [firstpage_image] =>[orig_patent_app_number] => 09484906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1295428 [patent_doc_number] => 06627193 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-30 [patent_title] => 'Methods and compositions for control of blood coagulation' [patent_app_type] => B1 [patent_app_number] => 09/482500 [patent_app_country] => US [patent_app_date] => 2000-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 10806 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/627/06627193.pdf [firstpage_image] =>[orig_patent_app_number] => 09482500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4192359 [patent_doc_number] => 06153738 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Contryphan peptides' [patent_app_type] => 1 [patent_app_number] => 9/466138 [patent_app_country] => US [patent_app_date] => 1999-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14743 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153738.pdf [firstpage_image] =>[orig_patent_app_number] => 466138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4352435 [patent_doc_number] => 06214975 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Method for evaluating target protein quality from fermenter' [patent_app_type] => 1 [patent_app_number] => 9/466711 [patent_app_country] => US [patent_app_date] => 1999-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 9840 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 193 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214975.pdf [firstpage_image] =>[orig_patent_app_number] => 466711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4314356 [patent_doc_number] => 06248353 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Reconstitution of purified membrane proteins into preformed liposomes' [patent_app_type] => 1 [patent_app_number] => 9/459137 [patent_app_country] => US [patent_app_date] => 1999-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7784 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248353.pdf [firstpage_image] =>[orig_patent_app_number] => 459137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 634272 [patent_doc_number] => 07129329 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-31 [patent_title] => 'Heme proteins hemAT-Hs and hemAT-Bs and their use in medicine and microsensors' [patent_app_type] => utility [patent_app_number] => 09/455978 [patent_app_country] => US [patent_app_date] => 1999-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 13671 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/129/07129329.pdf [firstpage_image] =>[orig_patent_app_number] => 09455978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7617179 [patent_doc_number] => 06946261 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-09-20 [patent_title] => 'Efficient methods for producing anti-microbial cationic peptides in host cells' [patent_app_type] => utility [patent_app_number] => 09/444281 [patent_app_country] => US [patent_app_date] => 1999-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 20707 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/946/06946261.pdf [firstpage_image] =>[orig_patent_app_number] => 09444281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1357499 [patent_doc_number] => 06573071 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Factor X analogues with a modified protease cleavage site' [patent_app_type] => B1 [patent_app_number] => 09/367791 [patent_app_country] => US [patent_app_date] => 1999-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19911 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573071.pdf [firstpage_image] =>[orig_patent_app_number] => 09367791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1162290 [patent_doc_number] => 06759216 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-06 [patent_title] => 'Glycosylated, low antigenicity low immunogenicity factor VIII' [patent_app_type] => B1 [patent_app_number] => 09/435403 [patent_app_country] => US [patent_app_date] => 1999-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1359 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759216.pdf [firstpage_image] =>[orig_patent_app_number] => 09435403 [rel_patent_id] =>[rel_patent_doc_number] =>)